pharma · Covid-19 · Chronic Myocardial Ischemia · LSTA
Lisata Therapeutics
LISATA THERAPEUTICS, INC.
Lisata Therapeutics is a pharma organization headquartered in basking ridge, USA. It trades on NYSE under ticker LSTA. Primary therapeutic focus areas include Covid-19, Chronic Myocardial Ischemia, Stage IV Melanoma, Kid
110 Allen Road, 2nd Flr, Basking Ridge, NJ 07920, US HQ
2006 Founded
38 Employees
Public company Type
LSTA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 110 Allen Road, 2nd Flr, Basking Ridge, NJ 07920, US
- Founded
- 2006
- Employees
- 38
- Programs
- 15
- Drugs
- 13
- Patents
- 1
CLBS16
Phase 2 · mab · Coronary Microvascular Dysfunction
CLBS16 for Coronary Microvascular Dysfunction is a Phase 2 program (mab) at LISATA THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).
Internal code CLBS16-P02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- LISATA THERAPEUTICS, INC.
- Phase
- Phase 2
- Modality
- mab
- Indication
- Coronary Microvascular Dysfunction
- Status
- terminated
- Trials
- 2